Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Peter W. Marks"'
Autor:
Peter W. Marks
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 213-215 (2023)
Externí odkaz:
https://doaj.org/article/384ad465c4be498e8771a9e570970524
Autor:
Osman N. Yogurtcu, Patrick R. Funk, Richard A. Forshee, Steven A. Anderson, Peter W. Marks, Hong Yang
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100325- (2023)
Since the authorization of the Moderna mRNA COVID-19 vaccine, real-world evidence has indicated its effectiveness in preventing COVID-19 cases. However, increased cases of mRNA vaccine-associated myocarditis/pericarditis have been reported, predomina
Externí odkaz:
https://doaj.org/article/417d3aad710b455d85c465befdc24769
Publikováno v:
New England Journal of Medicine. 388:1153-1155
Autor:
Robert M. Califf, Peter W. Marks
Publikováno v:
Science Translational Medicine. 15
Adequate and well-controlled clinical trials remain critical tools for helping to bring benefit to patients in medical need.
Autor:
Peter W. Marks, Ann T. Farrell, Charles S. Abrams, Kenneth C. Anderson, Brendan K. Dolan, William A. Wood, Sam Walters, Matthew Gertzog, Donna Neuberg, Alexis A. Thompson, Emily Tucker, Kathleen Hewitt, Paul G. Kluetz, Gregory Pappas, Robert M. Plovnick, Donna Rivera
Publikováno v:
Blood Advances. 5:5429-5438
The ASH Research Collaborative is a nonprofit organization established through the American Society of Hematology’s commitment to patients with hematologic conditions and the science that informs clinical care and future therapies. The ASH Research
Autor:
Osman N. Yogurtcu, Patrick R. Funk, Richard A. Forshee, Steven A. Anderson, Peter W. Marks, Hong Yang
Since authorization of the Moderna mRNA COVID-19 Vaccine, real-world evidence has indicated its effectiveness in preventing COVID-19 cases. However, increased cases of mRNA vaccine-associated myocarditis/pericarditis have been reported, predominantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ae2cf0f917179bcd85987cb937b602c
https://doi.org/10.1101/2022.12.02.22283050
https://doi.org/10.1101/2022.12.02.22283050
Autor:
Peter W. Marks
Publikováno v:
Rossi's Principles of Transfusion Medicine. :21-23
Autor:
Paula T. Hammond, Aravind Asokan, Donald B. Kohn, Matthew H. Porteus, Drew Weissman, Punam Malik, Hans-Peter Kiem, André Lieber, Paula M. Cannon, Peter W. Marks, Agnieszka Czechowicz, Els Verhoeyen, Irving L. Weissman
Publikováno v:
Hum Gene Ther
On May 11, 2020, the National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation (Gates Foundation) held an exploratory expert scientific roundtable to inform an NIH–Gates Foundation collaboration on the development of scalable, sus
Autor:
R. Scott Wright, Jonathon W. Senefeld, Brian P. Butterfield, Joshua J. Dennis, Elizabeth R. Lesser, Juan C. Diaz Soto, Chad C. Wiggins, Katie L. Kunze, Robert F. Rea, Matthew A. Sexton, Patrick W. Johnson, Peter W. Marks, Emily R. Whelan, Jeffrey L. Winters, Kathryn F. Larson, Nicole C. Verdun, Andrew J. Clayburn, Riley J. Regimbal, Matthew R. Spiegel, Matthew N.P. Vogt, Janis E. Blair, Philippe R. Bauer, Sarah E. Baker, Allan M. Klompas, Nigel Paneth, David O. Hodge, Noud van Helmond, Vitaly Herasevich, Michael J. Joyner, De Lisa Fairweather, John R. A. Shepherd, James R. Stubbs, Matthew R. Buras, Rickey E. Carter, Camille M. van Buskirk, Kylie J. Andersen, Arturo Casadevall, Juan G. Ripoll, Katelyn A. Bruno, Stephen A. Klassen
Publikováno v:
Mayo Clinic Proceedings
OBJECTIVE: To provide an update on key safety metrics after transfusion of convalescent plasma in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated safety in 5000 hospitalized patients. PATIENTS AND METHODS: From April
Publikováno v:
Haemophilia. 27:126-131
Introduction The goal of gene therapy for haemophilia is to alter the clinical phenotype to a milder form or even cure, by increasing endogenous coagulation factor levels through transfer of a functional gene encoding the respective deficient coagula